Last reviewed · How we verify
Iopanoicum (IOPANOIC ACID)
Iopanoicum (generic name: IOPANOIC ACID) is a iopanoic acid drug. It is currently FDA-approved (first approved 1951) for Diagnostic aid.
Iopanoic Acid (Iopanoicum) is a marketed diagnostic aid used for imaging the gallbladder and bile ducts, with a key composition patent expiring in 2028. Its primary strength lies in its established mechanism of being taken up by the liver and excreted in the bile, facilitating clear imaging. The primary risk is the presence of several same-class competitors, including iodoxamic acid, adipiodone, iocetamic acid, iopodic acid, and tyropanoate, which may limit market share and revenue growth.
At a glance
| Generic name | IOPANOIC ACID |
|---|---|
| Drug class | iopanoic acid |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
| First approval | 1951 |
Approved indications
- Diagnostic aid
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Iopanoicum CI brief — competitive landscape report
- Iopanoicum updates RSS · CI watch RSS
Frequently asked questions about Iopanoicum
What is Iopanoicum?
What is Iopanoicum used for?
What is the generic name of Iopanoicum?
What drug class is Iopanoicum in?
When was Iopanoicum approved?
What development phase is Iopanoicum in?
Related
- Drug class: All iopanoic acid drugs
- Therapeutic area: All drugs in Gastroenterology
- Indication: Drugs for Diagnostic aid
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing